Chemoradiotherapy could improve overall survival of patients with stage IV cutaneous squamous cell carcinoma: analysis of 34 cases

Br J Dermatol. 2019 Jun;180(6):1557-1558. doi: 10.1111/bjd.17792. Epub 2019 Mar 28.

Authors

A Hiura¹, K Yoshino¹, T Maeda¹, K Nagai¹, S Oaku¹, M Kato¹, Y Fujisawa²

Affiliations

¹ Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, 113-8677, Japan.
² Department of Dermatology, University of Tsukuba, Tsukuba, Japan.

PMID: 30791086
DOI: 10.1111/bjd.17792

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma, Squamous Cell / mortality
Carcinoma, Squamous Cell / pathology
Carcinoma, Squamous Cell / therapy*
Chemoradiotherapy*
Dose-Response Relationship, Drug
Dose-Response Relationship, Radiation
Feasibility Studies
Humans
Kaplan-Meier Estimate
Neoplasm Staging
Prognosis
Progression-Free Survival
Radiotherapy Dosage
Retrospective Studies
Skin Neoplasms / mortality
Skin Neoplasms / pathology
Skin Neoplasms / therapy*
Survival Rate